Skip to main content
Log in

Author’s Reply to Vaz et al.: “Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease”

  • Letter to the Editor
  • Published:
American Journal of Cardiovascular Drugs Aims and scope Submit manuscript

The Original Article was published on 11 August 2020

A Systematic Review to this article was published on 04 September 2019

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Vaz I, Kumar A, Shariff M, Doshi R. Comment on: Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease. Am J Cardiovasc Drugs. 2020. https://doi.org/10.1007/s40256-020-00412-2.

    Article  PubMed  Google Scholar 

  2. Fu Y, Zhu W, Zhou Y, Chen H, Yan L, He W. Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review. Am J Cardiovasc Drugs. 2020;20:139–47. https://doi.org/10.1007/s40256-019-00369-x.

    Article  PubMed  CAS  Google Scholar 

  3. Lee HF, Chan YH, Chang SH, Tu HT, Chen SW, Yeh YH, Wu LS, Kuo CF, Kuo CT, See LC. Efectiveness and safety of nonvitamin K antagonist oral anticoagulant and warfarin in cirrhotic patients with nonvalvular atrial fibrillation. J Am Heart Assoc. 2019;8(5):e011112.

    Article  Google Scholar 

  4. Lee S-R, Lee H-J, Choi E-K, Han K-D, Jung J-H, Cha M-J, Oh S, Lip GYH. Direct oral anticoagulants in patients with atrial fibrillation and liver disease. J Am Coll Cardiol. 2019;73(25):3295–308.

    Article  CAS  Google Scholar 

  5. Douros A, Azoulay L, Yin H, Suissa S, Renoux C. Non-vitamin K antagonist oral anticoagulants and risk of serious liver injury. J Am Coll Cardiol. 2018;71(10):1105–13.

    Article  CAS  Google Scholar 

  6. Alonso A, MacLehose RF, Chen LY, Bengtson LG, Chamberlain AM, Norby FL, Lutsey PL. Prospective study of oral anticoagulants and risk of liver injury in patients with atrial fibrillation. Heart. 2017;103(11):834–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Wenfeng He.

Ethics declarations

Funding

No external funds were used in preparing this reply.

Conflict of interest

Yonghui Fu, Wengen Zhu, Yue Zhou, He Chen, Lan Yan, and Wenfeng He declare that they have no potential conflicts of interest that might be relevant to this reply.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.

Code availability

Not applicable.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, Y., Zhu, W., Zhou, Y. et al. Author’s Reply to Vaz et al.: “Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients with Atrial Fibrillation and Liver Disease”. Am J Cardiovasc Drugs 20, 507–508 (2020). https://doi.org/10.1007/s40256-020-00413-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40256-020-00413-1

Navigation